These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33328051)

  • 1. Progress in examining cost-effectiveness of AI in diabetic retinopathy screening.
    Dismuke C
    Lancet Digit Health; 2020 May; 2(5):e212-e213. PubMed ID: 33328051
    [No Abstract]   [Full Text] [Related]  

  • 2. Artificial Intelligence in Community-Based Diabetic Retinopathy Telemedicine Screening in Urban China: Cost-effectiveness and Cost-Utility Analyses With Real-world Data.
    Lin S; Ma Y; Xu Y; Lu L; He J; Zhu J; Peng Y; Yu T; Congdon N; Zou H
    JMIR Public Health Surveill; 2023 Feb; 9():e41624. PubMed ID: 36821353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial intelligence for diabetic retinopathy screening, prediction and management.
    Gunasekeran DV; Ting DSW; Tan GSW; Wong TY
    Curr Opin Ophthalmol; 2020 Sep; 31(5):357-365. PubMed ID: 32740069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of Autonomous Point-of-Care Diabetic Retinopathy Screening for Pediatric Patients With Diabetes.
    Wolf RM; Channa R; Abramoff MD; Lehmann HP
    JAMA Ophthalmol; 2020 Oct; 138(10):1063-1069. PubMed ID: 32880616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health Economic and Safety Considerations for Artificial Intelligence Applications in Diabetic Retinopathy Screening.
    Xie Y; Gunasekeran DV; Balaskas K; Keane PA; Sim DA; Bachmann LM; Macrae C; Ting DSW
    Transl Vis Sci Technol; 2020 Apr; 9(2):22. PubMed ID: 32818083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of tele-ophthalmology in diabetic retinopathy screening.
    Kalogeropoulos D; Kalogeropoulos C; Stefaniotou M; Neofytou M
    J Optom; 2020; 13(4):262-268. PubMed ID: 31948924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of Artificial Intelligence as a Decision-Support System Applied to the Detection and Grading of Melanoma, Dental Caries, and Diabetic Retinopathy.
    Gomez Rossi J; Rojas-Perilla N; Krois J; Schwendicke F
    JAMA Netw Open; 2022 Mar; 5(3):e220269. PubMed ID: 35289862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Retinal Imaging and Portable Screening Devices in Tele-ophthalmology Applications for Diabetic Retinopathy Management.
    DeBuc DC
    Curr Diab Rep; 2016 Dec; 16(12):132. PubMed ID: 27841014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The era of artificial intelligence-based individualized telemedicine is coming.
    Jheng YC; Kao CL; Yarmishyn AA; Chou YB; Hsu CC; Lin TC; Hu HK; Ho TK; Chen PY; Kao ZK; Chen SJ; Hwang DK
    J Chin Med Assoc; 2020 Nov; 83(11):981-983. PubMed ID: 32568967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of artificial intelligence in screening for diabetic retinopathy in India.
    Rajalakshmi R
    Eye (Lond); 2020 Mar; 34(3):420-421. PubMed ID: 31827270
    [No Abstract]   [Full Text] [Related]  

  • 11. Great expectations and challenges of artificial intelligence in the screening of diabetic retinopathy.
    Zhao M; Jiang Y
    Eye (Lond); 2020 Mar; 34(3):418-419. PubMed ID: 31827269
    [No Abstract]   [Full Text] [Related]  

  • 12. Six-year prevalence and incidence of diabetic retinopathy and cost-effectiveness of tele-ophthalmology in Manitoba.
    Kanjee R; Dookeran RI; Mathen MK; Stockl FA; Leicht R
    Can J Ophthalmol; 2017 Nov; 52 Suppl 1():S15-S18. PubMed ID: 29074007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AI telemedicine screening in ophthalmology: health economic considerations.
    Teo ZL; Ting DSW
    Lancet Glob Health; 2023 Mar; 11(3):e318-e320. PubMed ID: 36702140
    [No Abstract]   [Full Text] [Related]  

  • 14. Eye Disease in Patients with Diabetes Screened with Telemedicine.
    Park DW; Mansberger SL
    Telemed J E Health; 2017 Feb; 23(2):113-118. PubMed ID: 27328169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telemedicine-based digital retinal imaging vs standard ophthalmologic evaluation for the assessment of diabetic retinopathy.
    Li Z; Wu C; Olayiwola JN; Hilaire DS; Huang JJ
    Conn Med; 2012 Feb; 76(2):85-90. PubMed ID: 22670358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Challenge of Diabetic Retinopathy Standardization in an Ophthalmological Dataset.
    Nakayama LF; Gonçalves MB; Ferraz DA; Santos HNV; Malerbi FK; Morales PH; Maia M; Regatier CVS; Belfort R
    J Diabetes Sci Technol; 2021 Nov; 15(6):1410-1411. PubMed ID: 34259085
    [No Abstract]   [Full Text] [Related]  

  • 17. Diabetic retinopathy screening: a systematic review of the economic evidence.
    Jones S; Edwards RT
    Diabet Med; 2010 Mar; 27(3):249-56. PubMed ID: 20536486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Six-year prevalence and incidence of diabetic retinopathy and cost-effectiveness of tele-ophthalmology in Manitoba.
    Kanjee R; Dookeran RI; Mathen MK; Stockl FA; Leicht R
    Can J Ophthalmol; 2016 Dec; 51(6):467-470. PubMed ID: 27938959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of a National Telemedicine Diabetic Retinopathy Screening Program in Singapore.
    Nguyen HV; Tan GS; Tapp RJ; Mital S; Ting DS; Wong HT; Tan CS; Laude A; Tai ES; Tan NC; Finkelstein EA; Wong TY; Lamoureux EL
    Ophthalmology; 2016 Dec; 123(12):2571-2580. PubMed ID: 27726962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remote screening of diabetic retinopathy through a community-wide teleophthalmology program in Mumbai.
    Kim E; Jain A; Sahu A; Kore S; Krishnan R; Natarajan S
    Indian J Ophthalmol; 2022 Jun; 70(6):2199. PubMed ID: 35648017
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.